Ferric carboxymaltose in patients with heart failure and iron deficiency

The New England Journal of Medicine
Stefan D AnkerFAIR-HF Trial Investigators

Abstract

Iron deficiency may impair aerobic performance. This study aimed to determine whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in patients who had heart failure, reduced left ventricular ejection fraction, and iron deficiency, either with or without anemia. We enrolled 459 patients with chronic heart failure of New York Heart Association (NYHA) functional class II or III, a left ventricular ejection fraction of 40% or less (for patients with NYHA class II) or 45% or less (for NYHA class III), iron deficiency (ferritin level <100 microg per liter or between 100 and 299 microg per liter, if the transferrin saturation was <20%), and a hemoglobin level of 95 to 135 g per liter. Patients were randomly assigned, in a 2:1 ratio, to receive 200 mg of intravenous iron (ferric carboxymaltose) or saline (placebo). The primary end points were the self-reported Patient Global Assessment and NYHA functional class, both at week 24. Secondary end points included the distance walked in 6 minutes and the health-related quality of life. Among the patients receiving ferric carboxymaltose, 50% reported being much or moderately improved, as compared with 28% of patients receiving placebo, according to the Patien...Continue Reading

References

Nov 1, 1996·Journal of the American College of Cardiology·A L ClarkA J Coats
Apr 12, 2000·Journal of the American College of Cardiology·C P GreenJ A Spertus
Aug 9, 2001·Annals of Medicine·R Rabin, F de Charro
May 16, 2003·The New England Journal of Medicine·Mariell Jessup, Susan Brozena
Jul 22, 2004·JAMA : the Journal of the American Medical Association·Véronique L RogerSteven J Jacobsen
Sep 19, 2006·Journal of the American College of Cardiology·Aidan P BolgerCallum M Chapman
Dec 19, 2006·Journal of the American College of Cardiology·John N NanasMaria I Anastasiou-Nana
Dec 30, 2006·Trends in Cell Biology·Louise L DunnDes R Richardson
Oct 24, 2007·Journal of the American College of Cardiology·Jorge Eduardo ToblliFederico Di Gennaro
May 20, 2008·CNS Drugs·Pankaj Satija, William G Ondo

❮ Previous
Next ❯

Citations

Mar 29, 2012·Zeitschrift für Gerontologie und Geriatrie·G RöhrigR J Schulz
May 30, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Nicolas JanusVincent Launay-Vacher
Dec 30, 2011·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Michael D EzekowitzUNKNOWN PASCAL Investigators
Dec 27, 2011·Transgenic Research·Li ZhangLianfeng Zhang
Sep 24, 2013·Current Atherosclerosis Reports·Emanuela LapiceOlga Vaccaro
Nov 9, 2010·Current Heart Failure Reports·Donald S SilverbergDov Wexler
Sep 4, 2012·Current Heart Failure Reports·Shanti Gunawardena, Mark E Dunlap
Oct 3, 2013·Current Heart Failure Reports·Meghana Halkar, W H Wilson Tang
May 31, 2012·Current Treatment Options in Cardiovascular Medicine·Donald S Silverberg, Doron Schwartz
Mar 1, 2012·Journal of Cardiovascular Translational Research·Jagdesh KandalaJagmeet P Singh
Aug 6, 2013·Drugs & Aging·Kannayiram AlagiakrishnanWilbert S Aronow
Jun 28, 2011·Nature Reviews. Drug Discovery·Juan Tamargo, José López-Sendón
Oct 7, 2010·Nature Reviews. Gastroenterology & Hepatology·Jürgen SteinAxel U Dignass
Oct 20, 2010·Nature Reviews. Nephrology·Anatole Besarab, Daniel W Coyne
Apr 29, 2010·Nature Reviews. Nephrology·Walter H Hörl
Nov 20, 2013·Nature Reviews. Nephrology·Branko BraamCarlo A Gaillard
Nov 14, 2012·Nature Reviews. Rheumatology·Günter Weiss, Georg Schett
Apr 23, 2010·The New England Journal of Medicine·José Vitale, Francesca Carbone
Aug 2, 2013·The New England Journal of Medicine·Karl SwedbergJames B Young
Nov 19, 2009·The New England Journal of Medicine·G William Dec
Mar 15, 2011·The American Journal of Bioethics : AJOB·Edward L Korn, Boris Freidlin
Jan 6, 2012·Age and Ageing·John Baxter, Theresa McDonagh
May 12, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AaproY Beguin
Oct 17, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T SteinmetzN Marschner
Mar 9, 2010·European Heart Journal·Peter S PangMihai Gheorghiade
Jun 24, 2010·European Heart Journal·Ewa A JankowskaPiotr Ponikowski
May 25, 2011·European Heart Journal·Alexander Van De BruaeneWerner Budts
Oct 27, 2012·European Heart Journal·Ewa A JankowskaPiotr Ponikowski
Nov 28, 2012·European Heart Journal·Ewa A JankowskaPiotr Ponikowski
May 15, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Lynda A SzczechJane E Onken
May 25, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A DavenportUNKNOWN Acute Dialysis Quality Initiative (ADQI) consensus group
Dec 31, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alejandro Martin-MaloPedro Aljama
Oct 1, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·George R BailieBruce M Robinson
Jan 3, 2012·QJM : Monthly Journal of the Association of Physicians·Donald S C AngA D Struthers
May 14, 2011·International Journal of Clinical Practice·M R Cowie, R Lucas
Aug 19, 2011·International Journal of Clinical Practice·M R Cowie, R Lucas
Nov 14, 2012·Acta Haematologica·Cristiane S WeberNadine Clausell
Jan 28, 2012·American Journal of Respiratory and Critical Care Medicine·Shailaja J HaydenErik R Swenson
Jan 18, 2011·Hematology·Michael Auerbach, Harold Ballard
Jan 18, 2011·Hematology·Jeffrey L Carson, John W Adamson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Journal of the American College of Cardiology
John N NanasMaria I Anastasiou-Nana
Circulation
Jalal K GhaliStudy of Anemia in Heart Failure Trial (STAMINA-HeFT) Group
Journal of the American College of Cardiology
Hessel F GroenveldPeter van der Meer
© 2022 Meta ULC. All rights reserved